Sale of offices in Sydney this week. On going trial of Telemedcare units in England results due in about 40 days. Opening of Canadian Factory soon and commencement of production expected by end of September Expected monthly sales of $4m with about a 40% profit margin. Possible third contracts Result of US Civilian Research & Development Foundation funded doubleblind, placebo-controlled clinical trial of its botanical immunomodulator ImmunoXel due by year end. Operational Protype of drug delivery platform due Q1 2011 And some other items that I may have missed.
I still have a concern with funding but surely with the above they should be able to arrange funding to cover cost until the money starts rolling in
DYOR as this is just my opinion
STI Price at posting:
1.1¢ Sentiment: Hold Disclosure: Held
